Cervical Plexus Hydrodissection with D5W for PTSD
Cervical Plexus Hydrodissection With D5W for PTSD Versus Delayed Treatment/Usual Care
NA · Dr. Dean Reeves Clinic · NCT04421573
This study tests whether a dextrose injection can help people with PTSD feel better compared to those who start treatment later.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 19 Years to 90 Years |
| Sex | All |
| Sponsor | Dr. Dean Reeves Clinic (other) |
| Locations | 4 sites (Lexington, Kentucky and 3 other locations) |
| Trial ID | NCT04421573 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the use of dextrose injection via cervical plexus hydrodissection as a treatment for PTSD, a chronic mental health condition. The study compares the effects of this intervention against a delayed treatment control group. The approach aims to provide a safer alternative to traditional treatments by avoiding the use of lidocaine, thus eliminating risks associated with its toxicity. Participants will be monitored over the course of a year to assess the efficacy of the treatment in alleviating PTSD symptoms.
Who should consider this trial
Good fit: Ideal candidates are individuals with chronic PTSD symptoms lasting over a year who have tried multiple medications and non-medication treatments without success.
Not a fit: Patients with severe needle phobia, active suicidal plans, or those with certain psychiatric disorders such as schizophrenia or bipolar disorder may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could offer a new, accessible option for patients suffering from PTSD who have not responded to conventional therapies.
How similar studies have performed: While similar approaches have shown promise in treating PTSD, this specific method of using dextrose hydrodissection has not been formally evaluated in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Not involved in another study of PTSD treatment * Reliable transportation * Comfortable with computers * Tried 2 or more medications for treatment of PTSD symptoms * Tried 2 or more non-medication treatments for PTSD symptom * No known life-threatening illness * Not taking daily narcotics * Not having 3or more alcoholic drinks on an average day * No active suicidal plans * No major surgery plans * No major life stress that might interfere with completing study * Symptoms for more than 1 year * Not planning to move for next 18 months. * Living within an hour of Portlland, OR, Madison, WI, or Lexington, KY * Wiling to provide 2 email and 2 phone contact methods * Willing to answer questions on multiple occasions over the course of a year. * Willing to be assigned to 3 months of usual care treatment * No diagnosis of schizophrenia, Borderline Personality Disorder, or Bipolar Disorder. * No severe needle phobia * Chronic pain ≤ 5/10 * PCL-C score ≥ 50 Exclusion Criteria: None separate from inclusion criteria
Where this trial is running
Lexington, Kentucky and 3 other locations
- Danesh Mazloomdoost — Lexington, Kentucky, United States (RECRUITING)
- Paul W. Johnson, D.O., Clinic. — Portland, Oregon, United States (RECRUITING)
- NW Regen — Tigard, Oregon, United States (RECRUITING)
- Eric Phillippi M.D. Clinic — Madison, Wisconsin, United States (RECRUITING)
Study contacts
- Principal investigator: Kenneth D Reeves, M.D. — Dr. Dean Reeves Clinic
- Study coordinator: Kenneth D Reeves, M.D.
- Email: DeanReevesMD@gmail.com
- Phone: 9133621600
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: PTSD, Dextrose, Hydrodissection, Cervical Plexus